Brief: Genscript Biotech Through Unit To Subscribe For Convertible Bonds In Amount Of US$70 Mln
May 14 (Reuters) - Genscript Biotech Corp 1548.HK :
* CO THROUGH UNIT TO SUBSCRIBE FOR CONVERTIBLE BONDS IN
AMOUNT OF
US$70 MILLION
* HILLHOUSE CAPITAL MANAGEMENT WILL SUBSCRIBE FOR SERIES A
PREFERRED OF PROBIO CAYMAN FOR US$150 MILLION
Source text for Eikon: ID:nHKSC7PLf
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale